19th Jan 2016 07:38
LONDON (Alliance News) - Quantum Pharma PLC on Tuesday said its adjusted earnings for the full year will miss market expectations due to delays in its niche pharmaceuticals pipeline.
Quantum said its adjusted earnings before interest, taxation, depreciation and amortisation for the year to the end of January will be around GBP12.7 million, compared to market expectations for GBP13.7 million.
The group said its niche pharmaceuticals arm experienced delays in its pipeline, which an internal review by the company put down to internal management and processes, supply chain issues and regulatory delays.
Due to these delays, the company expects its revenue and earnings growth for the financial year to January 2017 will be more moderate than initially anticipated.
The company will publish its final results on May 10.
By Sam Unsted; [email protected]; @SamUAtAlliance
Copyright 2016 Alliance News Limited. All Rights Reserved.
Related Shares:
Quantum Pharma